Top Point Of Care (PoC) Molecular Diagnostic companies

The 10 key players our Point Of Care (PoC) Molecular Diagnostic report profiles, and other companies free public records show in this market.

Key players in Point Of Care (PoC) Molecular Diagnostic

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Point Of Care (PoC) Molecular Diagnostic

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.

Top trial sponsors in Point Of Care (PoC) Molecular Diagnostic

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Merck & Co., Inc. 11 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Johnson & Johnson 8 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Novartis AG 7 active trials on ClinicalTrials.gov (opens in a new tab)
  4. bioLytical Laboratories 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Regeneron Pharmaceuticals 2 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Pfizer Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Sanofi 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Roche 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Point Of Care (PoC) Molecular Diagnostic reports by place

One report for each place. Each tile opens that place's report.

Regions 7

Countries 26

Compare all 33 places for Point Of Care (PoC) Molecular Diagnostic, with active trials

Get the full Point Of Care (PoC) Molecular Diagnostic report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.